BCSF Stock Analysis: Bain Capital Specialty | NYSE
Asset Management | NYSE, USA | Market Cap: 717m USD | 12M Return: -10.2% | US05684B1070 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.14M
EPS Trend: -85.6%
Qual. Beats: 1
Rev. Trend: -94.3%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 7.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bain Capital Specialty Finance, Inc. (BCSF) is a business development company (BDC) that provides direct loans to U.S. middle-market companies. The fund focuses on senior secured debt structures, including first lien, stretch senior, unitranche, and second lien investments, while also participating in mezzanine debt, junior securities, and secondary debt purchases. BCSF typically lends to companies generating EBITDA between $10 million and $150 million, targeting the lower middle-market segment of the direct lending space.
As a BDC, BCSF is a regulated investment company that must distribute at least 90% of its taxable income as dividends to shareholders, which generally makes its common stock yield-oriented. Listed on the NYSE since November 2018, the company operates within the asset management and custody banks sub-industry, reflecting its role in private credit rather than traditional commercial banking. Bain Capital Credit serves as the external investment adviser, providing sourcing, underwriting, and portfolio management capabilities through the broader Bain Capital platform.
- Floating-rate loan income expands as benchmark rates remain elevated
- Middle-market M&A slowdown pressures new loan origination volume
- Non-accruals rise as portfolio companies face refinancing pressure
| Net Income: 63.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.19 > 1.0 |
| NWC/Revenue: 107.4% < 20% (prev 39.86%; Δ 67.53% < -1%) |
| CFO/TA 0.03 > 3% & CFO 74.6m > Net Income 63.9m |
| Net Debt (1.39b) to EBITDA (114.5m): 12.10 < 3 |
| Current Ratio: 7.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.9m) vs 12m ago 0.00% < -2% |
| Gross Margin: 66.56% > 18% (prev 61.15%; Δ 5.40% > 0.5%) |
| Asset Turnover: 7.14% > 50% (prev 7.39%; Δ -0.25% > 0%) |
| Interest Coverage Ratio: 1.35 > 6 (EBIT TTM 109.3m / Interest Expense TTM 80.8m) |
| A: 0.08 (Total Current Assets 239.7m - Total Current Liabilities 32.9m) / Total Assets 2.62b |
| B: -0.03 (Retained Earnings -80.8m / Total Assets 2.62b) |
| C: 0.04 (EBIT TTM 109.3m / Avg Total Assets 2.70b) |
| D: 0.70 (Book Value of Equity 1.08b / Total Liabilities 1.54b) |
| Altman-Z'' = 1.43 = BB |
As of October 07, 2026, the stock is trading at USD 10.82 with a total of 477,543 shares traded. Over the past week, the price has changed by -3.65%, over one month by -3.42%, over three months by -10.78% and over the past year by -10.21%.
Current recommended Stop Loss: 10.40 (which is 3.9% or 1.6 ATR below the current price).
Bain Capital Specialty has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold BCSF.
- StrongBuy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.6 | 16.7% |
P/E Trailing = 11.1616
P/E Forward = 10.1112
P/S = 2.7156
P/B = 0.6647
P/EG = 1.0474
Revenue TTM = 192.6m USD
EBIT TTM = 109.3m USD
EBITDA TTM = 114.5m USD
Long Term Debt = unknown (none)
Short Term Debt = 600.0m USD (from shortTermDebt, last fiscal year)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.39b USD (calculated: Debt 1.50b - CCE 115.7m)
Enterprise Value = 2.10b USD (716.8m + Debt 1.50b - CCE 115.7m)
Interest Coverage Ratio = 1.35 (Ebit TTM 109.3m / Interest Expense TTM 80.8m)
EV/FCF = 28.20x (Enterprise Value 2.10b / FCF TTM 74.6m)
FCF Yield = 3.55% (FCF TTM 74.6m / Enterprise Value 2.10b)
FCF Margin = 38.71% (FCF TTM 74.6m / Revenue TTM 192.6m)
Net Margin = 33.20% (Net Income TTM 63.9m / Revenue TTM 192.6m)
Gross Margin = 66.56% ((Revenue TTM 192.6m - Cost of Revenue TTM 64.4m) / Revenue TTM)
Gross Margin QoQ = 78.38% (prev 72.55%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.10b / Total Assets 2.62b)
Interest Expense / Debt = 5.38% (Interest Expense 80.8m / Debt 1.50b)
Taxrate = 4.82% (3.24m / 67.2m)
NOPAT = 104.0m (EBIT 109.3m * (1 - 4.82%))
Current Ratio = 7.29 (Total Current Assets 239.7m / Total Current Liabilities 32.9m)
Debt / Equity = 1.39 (Debt 1.50b / totalStockholderEquity, last quarter 1.08b)
Debt / EBITDA = 12.10 (Net Debt 1.39b / EBITDA 114.5m)
Debt / FCF = 18.58 (Net Debt 1.39b / FCF TTM 74.6m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.37% (Net Income 63.9m / Total Assets 2.62b)
RoE = 5.79% (Net Income TTM 63.9m / Total Stockholder Equity 1.10b)
RoCE = 4.22% (EBIT 109.3m / Capital Employed (Total Assets 2.62b - Current Liab 32.9m))
RoIC = 3.27% (NOPAT 104.0m / Invested Capital 3.18b)
WACC = 6.08% (E(716.8m)/V(2.22b) * Re(8.09%) + D(1.50b)/V(2.22b) * Rd(5.38%) * (1-Tc(0.05)))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.95 | Cagr: 0.21%
[DCF] Terminal Value 73.10% ; FCFF base≈89.5m ; Y1≈78.5m ; Y5≈63.4m
[DCF] Fair Price = N/A (negative equity: EV 1.02b - Net Debt 1.39b = -367.5m; debt exceeds intrinsic value)
EPS Correlation: -85.63 | EPS CAGR: -6.31% | SUE: 1.01 | # QB: 1
Revenue Correlation: -94.28 | Revenue CAGR: -6.29% | SUE: -0.93 | # QB: -1
EPS current Quarter (2026-09-30): EPS=0.43 | Chg30d=-0.58% | Revisions=+40% | Analysts=4
EPS current Year (2026-12-31): EPS=1.64 | Chg30d=+0.00% | Revisions=-17% | GrowthEPS=-12.8% | GrowthRev=-8.6%
EPS next Year (2027-12-31): EPS=1.34 | Chg30d=+3.42% | Revisions=-50% | GrowthEPS=-18.4% | GrowthRev=-5.6%
[Analyst] Revisions Ratio: -18% (up=3, down=5)